PHARMACEUTICAL COMPOSITION CONTAINING DECURSIN

摘要

This invention relates to a nephrotoxicity inhibitor composition containing decursin and a pharmaceutically acceptable carrier. This invention also relates to an antineoplastic composition or antidiabetic composition containing decursin as a nephrotoxicity inhibitor and a pharmaceutically acceptable carrier. This invention also relates to a cancer-cell differentiation induction agent composition, especially human leukemia cell differentiation composition containing decursin as an active ingredient and a pharmaceutically acceptable carrier.